Analysis on the HBsAb Titers and Its Determinants After the First Immunization of Hepatitis B Vaccine Among Hospitalized Neonates

Weixi LI,Meng XIE,Panpan FAN,Yong JIANG,Dongchi ZHAO
DOI: https://doi.org/10.14188/j.1671-8852.2017.03.023
2017-01-01
Abstract:Objective:To investigate the HBsAb titers after the first immunization of recombinant yeastderived hepatitis B vaccines (YDVs) among hospitalized neonates and to study its determinants.Method:One thousand and two neonates,born during 2012 to 2014 in our hospital,were selected as subjects and vaccinated with first dosage of YDVs within 24 hours after birth.HBsAb titers were tested by chemiluminescence microparticle immunoassay and related information was collected through questionnaires.Univariate analysis and logistic regression model were used to analyze the related factor of HBsAb titers among those neonates.Results:After the first immunization of YDVs,the population of neonates with titers of fewer than 10 mIU/ml was 397,the population of titers of (10-99) mIU/ml was 294,the population of (100-1 000) mIU/ml was 252,and the population of over 1 000 mIU/ml was 59.The proportion of non-and-low antibody was 67.0%,in which the proportion of non antibody was 39.6% and the proportion of low antibody was 29.4%.Analysis from both univariate analysis and ordinal logistic regression model suggested that gestation,maternal HBsAb titers and maternal HBsAg were determinants of HBsAb titers for neonates,with the OR value of non-and-low antibody of 1.179 for gestation under 32 weeks,8.906 for maternal HBsAb under 10 mIU/ml,4.203 for maternal HBsAb between 10 and 99mIU/ml,and 3.134 for neonates whose mother was positive for HBsAg,respectively.Conclusion:Gestation under 32 weeks,maternal HBsAb under 100 mIU/ml and positive for maternal HBsAg had comparatively lower neonatal HBsAb titers for YDVs,suggesting that the HBsAb titers monitoring for these neonates should be strengthened.
What problem does this paper attempt to address?